NL300015I2 - 1,3-Dihydro-4- (aroyl) -2H-imidazole-2-ones and anti-hypertensive, cardiotonic and anti-thrombotic active pharmaceutical composition. - Google Patents

1,3-Dihydro-4- (aroyl) -2H-imidazole-2-ones and anti-hypertensive, cardiotonic and anti-thrombotic active pharmaceutical composition.

Info

Publication number
NL300015I2
NL300015I2 NL300015C NL300015C NL300015I2 NL 300015 I2 NL300015 I2 NL 300015I2 NL 300015 C NL300015 C NL 300015C NL 300015 C NL300015 C NL 300015C NL 300015 I2 NL300015 I2 NL 300015I2
Authority
NL
Netherlands
Prior art keywords
cardiotonic
aroyl
hypertensive
dihydro
imidazole
Prior art date
Application number
NL300015C
Other languages
Dutch (nl)
Other versions
NL300015I1 (en
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26727558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300015(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NL300015I2 publication Critical patent/NL300015I2/en
Publication of NL300015I1 publication Critical patent/NL300015I1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
NL300015C 1979-06-18 2000-09-04 1,3-Dihydro-4- (aroyl) -2H-imidazole-2-ones and anti-hypertensive, cardiotonic and anti-thrombotic active pharmaceutical composition. NL300015I1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4980879A 1979-06-18 1979-06-18
US11920780A 1980-02-07 1980-02-07

Publications (2)

Publication Number Publication Date
NL300015I2 true NL300015I2 (en) 2000-10-02
NL300015I1 NL300015I1 (en) 2000-11-01

Family

ID=26727558

Family Applications (2)

Application Number Title Priority Date Filing Date
NL8003498A NL193752C (en) 1979-06-18 1980-06-17 1,3-Dihydro-4- (aroyl) -2H-imidazole-2-ones and anti-hypertensive, cardiotonic and anti-thrombotic active pharmaceutical composition.
NL300015C NL300015I1 (en) 1979-06-18 2000-09-04 1,3-Dihydro-4- (aroyl) -2H-imidazole-2-ones and anti-hypertensive, cardiotonic and anti-thrombotic active pharmaceutical composition.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL8003498A NL193752C (en) 1979-06-18 1980-06-17 1,3-Dihydro-4- (aroyl) -2H-imidazole-2-ones and anti-hypertensive, cardiotonic and anti-thrombotic active pharmaceutical composition.

Country Status (20)

Country Link
AT (1) AT375349B (en)
AU (1) AU532783B2 (en)
CA (1) CA1132554A (en)
CH (1) CH646155A5 (en)
DE (1) DE3021792A1 (en)
DK (1) DK160269C (en)
ES (1) ES8105299A1 (en)
FR (1) FR2459233A1 (en)
GB (1) GB2055364B (en)
HK (1) HK61486A (en)
HU (1) HU186736B (en)
IE (1) IE50646B1 (en)
IL (1) IL60243A (en)
IT (1) IT1143922B (en)
MY (1) MY8600709A (en)
NL (2) NL193752C (en)
NO (1) NO152841C (en)
NZ (1) NZ193935A (en)
PH (1) PH18683A (en)
SE (2) SE447107B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
US4329471A (en) * 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 4-(4-Phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
US4526981A (en) * 1981-05-04 1985-07-02 Merrell Dow Pharmaceuticals Inc. [1,2-Dihydro-4(5)-acyl-2-oxo-2H-imidazol-4(5)-yl] methyl nitrates
US4371737A (en) * 1981-05-04 1983-02-01 Merrell Dow Pharmaceuticals Inc. 5-Aminomethyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4381393A (en) * 1981-05-04 1983-04-26 Merrell Dow Pharmaceuticals Inc. 4-Aminomethyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
JPS57185266A (en) * 1981-05-04 1982-11-15 Merrell Dow Pharma 4-oxymethyl-5-acyl-1,3-dihydro-2h-imidazole- 2-one
US4329470A (en) * 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 5-(4-Phenyl 1-piperidinyl)methyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4410540A (en) * 1981-11-04 1983-10-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic 4-aroylimidazolidin-2-ones
US4367236A (en) 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
JP2007530566A (en) * 2004-03-22 2007-11-01 ミオゲン インコーポレイティッド (R) -Enoximone sulfoxide and its use in the treatment of PDE-III mediated diseases
EP1737448A1 (en) * 2004-03-22 2007-01-03 Myogen, Inc. (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
JP2009514969A (en) 2005-11-09 2009-04-09 コンビナトアールエックス インコーポレーティッド Methods, compositions, and kits for treating medical conditions
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2688161C (en) 2007-06-04 2020-10-20 Kunwar Shailubhai Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2522968T3 (en) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (en) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and others
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (en) 2011-03-01 2018-10-19 辛纳吉制药公司 The method for preparing guanosine cyclic mono-phosphate agonist
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
WO2014131024A2 (en) 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (en) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same
MX2016001714A (en) 2013-08-09 2016-10-03 Ardelyx Inc Compounds and methods for inhibiting phosphate transport.
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
CN114539157B (en) * 2022-03-03 2023-12-22 曲靖师范学院 Method for preparing 4-iodo-N-aryl pyrazole compound by iodine-promoted oxidation method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them

Also Published As

Publication number Publication date
NL8003498A (en) 1980-12-22
SE8501452D0 (en) 1985-03-25
NO152841B (en) 1985-08-19
NL193752C (en) 2000-09-04
PH18683A (en) 1985-08-29
GB2055364A (en) 1981-03-04
HU186736B (en) 1985-09-30
IE50646B1 (en) 1986-06-11
NZ193935A (en) 1985-05-31
SE447107B (en) 1986-10-27
SE464559B (en) 1991-05-13
MY8600709A (en) 1986-12-31
IL60243A0 (en) 1980-09-16
IE801162L (en) 1980-12-18
AU5911880A (en) 1981-01-08
NL193752B (en) 2000-05-01
GB2055364B (en) 1983-06-08
DE3021792A1 (en) 1981-01-22
AT375349B (en) 1984-07-25
HK61486A (en) 1986-08-29
DK160269C (en) 1991-07-22
ES492255A0 (en) 1981-06-01
IT1143922B (en) 1986-10-29
ATA314280A (en) 1983-12-15
FR2459233A1 (en) 1981-01-09
FR2459233B1 (en) 1983-09-23
NO801796L (en) 1980-12-19
CH646155A5 (en) 1984-11-15
DK259080A (en) 1980-12-19
SE8501452L (en) 1985-03-25
NO152841C (en) 1985-11-27
ES8105299A1 (en) 1981-06-01
NL300015I1 (en) 2000-11-01
SE8004253L (en) 1980-12-19
DE3021792C2 (en) 1989-08-10
IT8048997A0 (en) 1980-06-17
CA1132554A (en) 1982-09-28
DK160269B (en) 1991-02-18
IL60243A (en) 1987-01-30
AU532783B2 (en) 1983-10-13

Similar Documents

Publication Publication Date Title
NL193752B (en) 1,3-Dihydro-4- (aroyl) -2H-imidazole-2-ones and anti-hypertensive, cardiotonic and anti-thrombotic active pharmaceutical composition.
NO851881L (en) DEVICE FOR THE DELIVERY OF VOCABLE, ACTIVE MATERIALS.
NL193907B (en) Basic ether and pharmaceutical composition containing the basic ether as the active ingredient.
IT1190824B (en) PHARMACEUTICAL COMPOSITION CONTAINING 24.25-DIHYDROXICOLECALCIFEROL AS ACTIVE INGREDIENT
NL990010I1 (en) Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-one derivatives and pharmaceutical compositions containing these derivatives.
BE848496A (en) AMINO-ALCOHOLS DERIVATIVES, THEIR PREPARATION AND USE, AND COMPOSITIONS CONTAINING SUCH DERIVATIVES.
IT7927614A0 (en) 1,2,4,5-TETRA-ALKYL-4-ARYLPIPERIDINES AND RELATED PHARMACEUTICAL FORMULATIONS.
IT7830075A0 (en) METHYLADAMANTYL HYDRAZINES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
MX9203148A (en) 2,6-DIALCOXIPENZAMIDES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
OA06326A (en) Composition fungicides and their preparation.
IT8021550A0 (en) ADENOSINE DERIVATIVES WITH ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY AND THERAPEUTIC COMPOSITIONS WHICH CONTAIN THEM AS THE ACTIVE INGREDIENT.
IT7927243A0 (en) FOR THEIR PREPARATION AND TRIAZINONE COMPOUNDS, PROCEDURES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
DE3785912D1 (en) UNSATURED COPOLYMER COMPOSITION.
GB2048856B (en) 1,1,3,5-substituted biuret compounds and pharmaceutical composition containing the same
BE839468A (en) NEWS 3-CHLORO-5,6-DIARYL-1,2,4-TRIAZINES AND THEIR USE AS LOCAL ANTI-INFLAMMATORY AGENTS
OA07187A (en) Pesticide compositions, their preparation and use.
NL7711777A (en) BIOLOGICALLY ACTIVE TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN THOSE COMPOUNDS AS THE ACTIVE INGREDIENT.
ATE1858T1 (en) 15-METHANESULFONAMIDOPROSTAGLANDIN DERIVATIVES, THEIR PHARMACEUTICAL COMPOSITIONS AND METHOD THEREOF.
IT8023422A0 (en) 5-(4-PYRIDINIL)-2 (1H)-PYRIDINONES, USEFUL AS CARDIOTONIC AGENTS, AND THEIR PREPARATION.
NL190120C (en) 2,3-DIHYDRO-4H-1-BENZOPYRAN-4-ON-0-CARBAMOYLOXIMES AND THEIR PHARMACEUTICAL PREPARATION THEREOF.
DE3482557D1 (en) 3-METHYLBUTEN-1-POLYMER, THEIR COMPOSITION AND CASTING FORM.
DE3875835T2 (en) ANTIVIRAL, ANTITUMORACTIVE AND FUNGICIDAL COMPOSITIONS.
NL174646C (en) 6,7-DIMETHOXY-4-AMINO-2-PIPERIDINOQUINAZOLINS AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
CA1004597A (en) Pharmaceutical compositions containing 7-bromo-1,3-dihydro-5-(2-pyridyl)-2h-1,4- benzodiazepin-2-one and n-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulphamoylbenzamide
MX9203174A (en) PHARMACEUTICAL COMPOSITION WITH ANTI-PHYLOGISTIC, ANTI-PYRECTIC AND ANTALGICAL ACTIVITY.